EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uso de ácido acetilsalicílico na prevenção da pré-eclâmpsia: uma revisão integrativa da literatura.

Bruno Kenji Curatolo Yokoyama, Bruna Klingelfus de Carvalho, Ithalo Oliveira Miranda, Renato Grun Bueno, Vinicius Ribeiro de Oliveira

Revista ft · 27.05.2026 · 30 (158) · 01-12

DOI: 10.69849/kyft5t77 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 27.05.2026. Verfasst von Bruno Kenji Curatolo Yokoyama und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia (PE) remains one of the leading causes of maternal and perinatal morbidity and mortality worldwide, characterized by a multisystem syndrome of complex etiology. Acetylsalicylic acid (ASA) in low doses has been consolidated as the main pharmacological strategy for the prophylaxis of the disease in high-risk pregnant women. This integrative literature review aimed to analyze and synthesize the scientific evidence published between 2016 and 2025 on the efficacy, optimal dose, and timing for initiating ASA therapy. The search was carried out in the PubMed, SciELO, LILACS, Cochrane Library and BVS databases. The results demonstrate that the administration of ASA at doses between 100 mg and 150 mg per day, preferably started between the 12th and 16th week of gestation, significantly reduces the incidence of preterm preeclampsia, with risk reductions of up to 62% in populations selected by pooled screening algorithms. In the Brazilian scenario, the implementation of this evidence faces logistical and standardization challenges in the Unified Health System (SUS). It is concluded that the prophylactic use of aspirin is a safe and cost-effective intervention, as long as screening is early and patient adherence is guaranteed.

Zitieren

APA

Yokoyama, B. K. C., Carvalho, B. K. D., Miranda, I. O., Bueno, R. G., & Oliveira, V. R. D. (2026). Uso de ácido acetilsalicílico na prevenção da pré-eclâmpsia: uma revisão integrativa da literatura. Revista ft, 30(158), 01-12. https://doi.org/10.69849/kyft5t77

Vancouver

Yokoyama BKC, Carvalho BKD, Miranda IO, Bueno RG, Oliveira VRD. Uso de ácido acetilsalicílico na prevenção da pré-eclâmpsia: uma revisão integrativa da literatura. Revista ft. 2026;30(158):01-12. doi:10.69849/kyft5t77

BibTeX
@article{Yokoyama2026,
  author = {Yokoyama, Bruno Kenji Curatolo and Carvalho, Bruna Klingelfus de and Miranda, Ithalo Oliveira and Bueno, Renato Grun and Oliveira, Vinicius Ribeiro de},
  title = {Uso de ácido acetilsalicílico na prevenção da pré-eclâmpsia: uma revisão integrativa da literatura},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {158},
  pages = {01--12},
  doi = {10.69849/kyft5t77}
}
Kostenlos starten →